Post-marketing studies of new insulins: Sales or science?

BMJ (Online)

Volumn 344, Issue 7862, 2012, Pages

  Gale, Edwin A M ^a,b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b SOUTHMEAD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN DERIVATIVE; INSULIN DETEMIR; ISOPHANE INSULIN; ANTIDIABETIC AGENT; DRUG DERIVATIVE; INSULIN;

COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG EFFICACY; DRUG INDUSTRY; DRUG MARKETING; DRUG RESEARCH; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; FOOD AND DRUG ADMINISTRATION; GLUCOSE BLOOD LEVEL; GOOD CLINICAL PRACTICE; HEALTH CARE COST; HUMAN; HYPOGLYCEMIA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; QUESTIONNAIRE; REVIEW; DRUG SUBSTITUTION; ECONOMICS; MARKETING; METHODOLOGY; MULTICENTER STUDY (TOPIC); PHASE 4 CLINICAL TRIAL (TOPIC);

CLINICAL TRIALS, PHASE IV AS TOPIC; DIABETES MELLITUS, TYPE 2; DRUG INDUSTRY; DRUG SUBSTITUTION; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MARKETING; MULTICENTER STUDIES AS TOPIC; PRODUCT SURVEILLANCE, POSTMARKETING;

EID: 84862698727     PISSN: 17561833     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.e3974     Document Type: Review

References (24)

1. Kessler DA, Rose JL, Temple RJ, Schapiro R, Griffin JP. Therapeutic-class wars-drug promotion in a competitive marketplace. N Engl J Med 1994;331:1350-3. (Pubitemid 24347007)
2. Hill KP, Ross JS, Egilman DS, Krumholz HM. The ADVANTAGE seeding trial: a review of internal documents. Ann Intern Med 2008;149:251-8.
3. Sox HC, Rennie D. Seeding trials: just say "no". Ann Intern Med 2008;149:179-280.
4. European Medicines Agency. Guideline on good pharmacovigilance practices. Module VIII-post-authorisation safety studies. URL here.
5. ClinicalTrials.gov URL here.
6. Mann CJ. Observational research methods. Research design II: cohort, cross-sectional, and case-control studies. Emerg Med J 2003;20:54-60. (Pubitemid 36163532)
7. Guidance for industry. Good pharmacovigilance practices and pharmacoepidemiologic assessment . US Department of Health and Human Services, Food and Drug Administration, 2005.
8. Gale EAM. Diabetes in the UK: time for a reality check? Diabet Med 2010;27:973-6.
9. Richter B, Neises G. "Human" insulin versus animal insulin in people with diabetes mellitus. Cochrane Database Syst Rev 2005;(1):CD003816.
10. Singh SR, Ahmad F, Lal A, Yu C, Bai Z, Bennett H. Efficacy and safety of insulin analogues for the management of diabetes mellitus: a meta-analysis. CMAJ 2009;180:385-97.
11. National Institute for Health and Clinical Excellence. The management of type 2 diabetes. NICE clinical guideline 87 . NICE, 2009. URL here.
12. Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, et al. Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 2009;52:17-30.
13. Holleman F, Gale EAM. Nice insulins, pity about the evidence. Diabetologia 2007;50:1783-90. (Pubitemid 47222873)
14. WHO 18th Expert Committee on the selection and use of essential medicines. Review of the evidence comparing insulin (human or animal) with analogue insulins. 2011. URL here.
15. Clinical Trials at Novo Nordisk. URL here.
16. Khutsoane D, Sharma SK, Almustafa M, Jang HC, Azar ST, Danciulescu R, et al. Biphasic insulin aspart 30 treatment improves glycaemic control in patients with type 2 diabetes in a clinical practice setting: experience from the PRESENT study. Diabetes Obes Metab 2008;10:212-22. (Pubitemid 351247337)
17. Home P, El Naggar N, Khamseh M, Gonzalez-Galvez G, Shen C, Chakkarwar P, et al. An observational non-interventional study of people with diabetes beginning or changed to insulin analogue therapy in non-Western countries: the A1chieve study. Diabetes Res Clin Pract 2011;94:352-63.
18. Health Action International. Life saving insulin largely unaffordable-a one day snapshot of the price of insulin across 60 countries. 2010. URL here.
19. Lüddeke H-J, Sreenan S, Aczel S, Maxeiner S, Yenigun M, Kozlovski P. PREDICTIVE-a global, prospective observational study to evaluate insulin detemir treatment in types 1 and 2 diabetes: baseline characteristics and predictors of hypoglycaemia from the European cohort. Diabetes Obes Metab 2007;9:428-34. (Pubitemid 46502063)
20. Yorkshire and Humber Public Health Observatory. Prescribing for diabetes in England-an update: 2002-2009. 2009. URL here.
21. Psaty B, Rennie D. Clinical trial investigators and their prescribing patterns. Another dimension to the relationship between physician investigators and the pharmaceutical industry. JAMA 2006;295:2787-90.
22. ENCEPP considerations on the definition of non-interventional trials under the current legislative framework ("Clinical Trials Directive" 2001/20/EC). 2011. URL here.
23. Silverman SL. From randomized controlled trials to observational studies. Am J Med 2009;122:114-20.
24. Lilly Diabetes. Observational studies. Diabetes: real people, real-world research. 2011. URL here.